Literature DB >> 12170329

Comparison of Trypanosoma cruzi infection in dogs inoculated with blood or metacyclic trypomastigotes of Berenice-62 and Berenice-78 strains via intraperitoneal and conjunctival routes.

Maria Terezinha Bahia1, Washington Luiz Tafuri, Marcelo Vidigal Caliari, Vanja Maria Veloso, Cláudia Martins Carneiro, George Luiz Lins Machado Coelho, Marta Lana.   

Abstract

This paper aimed to verify the influence of the inoculum source (blood or metacyclic trypomastigote) and the route of inoculation (intraperitoneal or conjunctival) on the course of T. cruzi infection in dogs, using comparatively the T. cruzi strains Berenice-62 and Berenice-78. All dogs inoculated intraperitoneally became infected independently of the T. cruzi strain and source of trypomastigotes used. High level of infectivity was also observed when metacyclic trypomastigotes of both strains were inoculated by conjunctival route. However, when blood trypomastigotes were inoculated by conjunctival route the percentages of infectivity were significantly lower in dogs inoculated with both strains. Parasitaemia was significantly higher in animals infected with metacyclic trypomastigotes via the conjunctival route independently of the T. cruzi strain used. All animals infected with Berenice-78 strain showed severe acute myocarditis. On the other hand, animals infected with Berenice-62 showed severe acute myocarditis only when infected with metacyclic trypomastigote, via the intraperitoneal route. The results suggest that the source of the inoculum and the route of inoculation remarkably influence the evolution of the infection for the T. cruzi in the vertebrate host even when the same strain of the parasite is used.

Entities:  

Mesh:

Year:  2002        PMID: 12170329     DOI: 10.1590/s0037-86822002000400010

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  10 in total

1.  Trypanosoma cruzi Infection Does Not Decrease Survival or Reproduction of the Common Bed Bug, Cimex lectularius.

Authors:  Jennifer K Peterson; Renzo Salazar; Ricardo Castillo-Neyra; Katty Borrini-Mayori; Carlos Condori; Casey Bartow-McKenney; Dylan Tracy; César Náquira; Michael Z Levy
Journal:  Am J Trop Med Hyg       Date:  2018-01-18       Impact factor: 2.345

2.  Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.

Authors:  Lourena E Costa; Mayara I S Lima; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Vivian T Martins; Mariana C Duarte; Paula S Lage; Eliane G P Lopes; Daniela P Lage; Tatiana G Ribeiro; Pedro H R Andrade; Danielle F de Magalhães-Soares; Manuel Soto; Carlos A P Tavares; Luiz R Goulart; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

3.  Rhodnius prolixus Life History Outcomes Differ when Infected with Different Trypanosoma cruzi I Strains.

Authors:  Jennifer K Peterson; Andrea L Graham; Andrew P Dobson; Omar Triana Chávez
Journal:  Am J Trop Med Hyg       Date:  2015-06-15       Impact factor: 2.345

4.  A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.

Authors:  Vivian T Martins; Mariana C Duarte; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Cecília S P Coelho; Danielle F de Magalhães-Soares; Ana Paula Fernandes; Manuel Soto; Carlos A P Tavares; Eduardo A F Coelho
Journal:  Parasit Vectors       Date:  2015-07-11       Impact factor: 3.876

5.  Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells.

Authors:  Igor Cestari; Marcel I Ramirez
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

6.  Sensitive and specific serodiagnosis of Leishmania infantum infection in dogs by using peptides selected from hypothetical proteins identified by an immunoproteomic approach.

Authors:  Miguel A Chávez-Fumagalli; Vivian T Martins; Miriam C S Testasicca; Daniela P Lage; Lourena E Costa; Paula S Lage; Mariana C Duarte; Henrique G Ker; Tatiana G Ribeiro; Fernando A A Carvalho; Wiliam C B Régis; Alexandre B Dos Reis; Carlos A P Tavares; Manuel Soto; Ana Paula Fernandes; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2013-04-03

7.  Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model.

Authors:  Olivia Rodríguez-Morales; M Magdalena Pérez-Leyva; Martha A Ballinas-Verdugo; Silvia C Carrillo-Sánchez; J Luis Rosales-Encina; Ricardo Alejandre-Aguilar; Pedro A Reyes; Minerva Arce-Fonseca
Journal:  Vet Res       Date:  2012-11-13       Impact factor: 3.683

8.  Echocardiographic Measurements in a Preclinical Model of Chronic Chagasic Cardiomyopathy in Dogs: Validation and Reproducibility.

Authors:  Eduardo B Carvalho; Isalira P R Ramos; Alvaro F S Nascimento; Guilherme V Brasil; Debora B Mello; Martin Oti; Michael Sammeth; Maria T Bahia; Antonio C Campos de Carvalho; Adriana B Carvalho
Journal:  Front Cell Infect Microbiol       Date:  2019-09-24       Impact factor: 5.293

Review 9.  Technological advances in the serological diagnosis of Chagas disease in dogs and cats: a systematic review.

Authors:  Natália Erdens Maron Freitas; Fernanda Lopes Habib; Emily Ferreira Santos; Ângelo Antônio Oliveira Silva; Natália Dantas Fontes; Leonardo Maia Leony; Daniel Dias Sampaio; Marcio Cerqueira de Almeida; Filipe Dantas-Torres; Fred Luciano Neves Santos
Journal:  Parasit Vectors       Date:  2022-09-27       Impact factor: 4.047

10.  Effect of the plasmid-DNA vaccination on macroscopic and microscopic damage caused by the experimental chronic Trypanosoma cruzi infection in the canine model.

Authors:  Olivia Rodríguez-Morales; Silvia C Carrillo-Sánchez; Humberto García-Mendoza; Alberto Aranda-Fraustro; Martha A Ballinas-Verdugo; Ricardo Alejandre-Aguilar; José Luis Rosales-Encina; Maite Vallejo; Minerva Arce-Fonseca
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.